Aims This study aimed to assess the impact of different antidiabetic agents on individuals
with diabetes and COVID-19. Methods We searched PubMed, Web of Science, Embase …

Aims We conducted a systematic review and meta-analysis to assess various antidiabetic
agents' association with mortality in patients with type 2 diabetes (T2DM) who have …

Background and Aims During the current Coronavirus Disease 2019 (COVID-19) pandemic,
patients with diabetes face disproportionately more. This study was performed to clarify anti …

Objectives To investigate the association between baseline use of glucose-lowering drugs
and serious clinical outcome among patients with type 2 diabetes. Design Territory-wide …

Background Diabetes is an independent predictor of poor outcomes in patients with COVID-
19. We compared the effects of the preadmission use of antidiabetic medications on the in …

Aims Rising prevalence of non-communicable diseases world-wide has made diabetes an
important comorbidity in patients with coronavirus disease-19 (COVID-19). We sought to …

Background Patients with diabetes are more likely to suffer COVID‐19 complications. Using
noninsulin antihyperglycemic medications (AGMs) during COVID‐19 infection has proved …

Aim COVID-19 has spread globally with heavy impact on most countries and our therapeutic
strategies in COVID-19 patients with diabetes are still limited. Recently, some new …

Abstract Background‐Aim Diabetes, obesity and hypertension are common comorbidities
associated with increased severity and mortality rates from Corona Virus Disease (COVID) …

Background and Objective Recently, insulin treatment has been found to be associated with
increased mortality and other adverse outcomes in patients with coronavirus disease 2019 …